Authors:
Garnick, MB
Fair, WR
Bostwick, D
Debruyne, F
Fourcroy, J
Grignon, D
Porterfield, H
Sufrin, G
Thrasher, B
Hart, C
Citation: Mb. Garnick et al., Fifth International Conference on Neoadjuvant Hormonal Therapy for Prostate Cancer - Overview consensus statement, MOL UROL, 4(3), 2000, pp. 89-92
Authors:
Garnick, M
Grignon, DJ
Klotz, L
Fair, W
Bostwick, D
Stone, N
Porterfield, H
Garzotto, M
Moul, J
Bruchovsky, N
Heston, W
Citation: M. Garnick et al., Significance of the Gleason scoring system after neoadjuvant hormonal therapy - Open discussion following Dr. Grignon's presentation, MOL UROL, 4(3), 2000, pp. 131-131
Authors:
Fair, W
Krane, RJ
Zietman, A
Porterfield, H
Citation: W. Fair et al., Urinary incontinence after treatment for localized prostate cancer - Open discussion following Dr. Krane's presentation, MOL UROL, 4(3), 2000, pp. 287-287
Authors:
Debruyne, F
Fair, W
Porterfield, H
Fourcroy, J
Garnick, M
Citation: F. Debruyne et al., UsToo PC-SPES surveys: Review of studies and update of previous survey results - Open discussion following Mr. Porterfield's presentation, MOL UROL, 4(3), 2000, pp. 293-293
Authors:
Garnick, MB
Fair, WR
Goldenberg, SL
Gleave, M
Grignon, D
Fourcroy, J
Sufrin, G
Porterfield, H
Hart, C
Citation: Mb. Garnick et al., Fourth International Conference on Neoadjuvant Hormonal Therapy of Prostate Cancer - March 12-13, 1999 - Boston, Massachusetts - Overview consensus statement, MOL UROL, 3(3), 1999, pp. 171-174
Citation: H. Porterfield, Survey of UsToo members and other prostate cancer patients to evaluate theefficacy and safety of PC-SPES, MOL UROL, 3(3), 1999, pp. 333-335
Authors:
Garnick, MB
Fair, WR
Goldenberg, SL
Gleave, M
Fourcroy, J
Grignon, D
Srougi, M
Porterfield, H
Hart, C
Citation: Mb. Garnick et al., Third International Conference on Neoadjuvant Hormonal Therapy of ProstateCancer: Overview consensus statement, MOL UROL, 2(3), 1998, pp. 87-89